Research & Discovery
UConn Puts Seven On List Of World’s Most Highly-Cited Researchers
Six UConn faculty members were named to a list of researchers with significant influence in their fields.
Nature Features Brain Cancer Research From UConn Health, JAX
Two UConn medical students join UConn Health’s neurosurgery chief among a worldwide research collaborative reporting progress toward a better understanding of the behavior of certain brain tumor cells, and ultimately, better treatments and prognoses.
Maternal Nutrition Across Generations of Livestock
UConn researchers will try to identify mechanisms that alter growth and efficiency across multiple generations of livestock, thanks to a new grant from the USDA.
Turning on Silenced Genes in Prader-Willi Research
A UConn Health research team has received nearly $3 million from the NIH to investigate the molecular underpinnings of Prader-Willi syndrome, a rare neurogenetic disorder.
Turning to Old Remedies For New Health Challenges
UConn researchers are experimenting with old approaches to solve a growing problem: potentially deadly pathogens that are resistant to antibiotics.
Meet the Researcher: Samantha Siedlecki, Marine Sciences
Samantha Siedlecki spearheads research on coastal environments, and is currently developing a regional model of ocean acidification for the East Coast.
Not Only Adorable: Squid Open Up New Antimicrobial Drug Possibilities
The glowing Hawaiian bobtail squid is more than a pretty face: New research shows that its symbiotic bacteria create antifungal compounds, which may be of use in drug discovery.
Breaking CO2 faster, cheaper, and more efficiently
A new discovery could make it possible to economically turn carbon dioxide into fuels.
Q&A: The Dangers of Vaping
UConn Health’s Dr. Mario F Perez, assistant professor of medicine at UConn School of Medicine, discusses his research pointing to potential dangers associated with vaping.
The Heart of the Matter: Genome Editing for Cardiovascular Diseases
Joint researcher from UConn Health and JAX, J. Travis Hinson's $3M grant is a pivotal step toward realizing the promise of genome editing and human precision medicine of cardiovascular and other disorders.